Cargando…

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells

Somatostatin (SST) analogues are used to control the proliferation and symptoms of neuroendocrine tumors (NETs). MicroRNAs (miRNA) are small non-coding RNAs that modulate posttranscriptional gene expression. We wanted to characterize the miRNAs operating under the control of SST to elucidate to what...

Descripción completa

Detalles Bibliográficos
Autores principales:	Døssing, Kristina B. V., Kjær, Christina, Vikeså, Jonas, Binderup, Tina, Knigge, Ulrich, Culler, Michael D., Kjær, Andreas, Federspiel, Birgitte, Friis-Hansen, Lennart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070923/ https://www.ncbi.nlm.nih.gov/pubmed/29973528 http://dx.doi.org/10.3390/genes9070337

Ejemplares similares

Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1
por: Døssing, Kristina B. V., et al.
Publicado: (2014)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
por: Nielsen, Kirstine, et al.
Publicado: (2020)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation
por: Zhou, Xin, et al.
Publicado: (2022)

From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia
por: Frazier, Sonya, et al.
Publicado: (2020)

miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression
por: Gurbuz, Venhar, et al.
Publicado: (2021)

miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met
por: Wang, Wen, et al.
Publicado: (2018)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

Prognostic value of expression levels of miR-148a, miR-152 and HLA-G in colon cancer
por: Emirzeoglu, Levent, et al.
Publicado: (2022)

miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
por: Bou Kheir, Tony, et al.
Publicado: (2011)

miR-148 family members are putative biomarkers for sepsis
por: Dong, Lei, et al.
Publicado: (2019)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Exploring the potential value of miR-148b-3p, miR-151b and miR-27b-3p as biomarkers in acute ischemic stroke
por: Cheng, Xiuli, et al.
Publicado: (2018)

Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells
por: Xiang, Min, et al.
Publicado: (2019)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
por: Song, Bin, et al.
Publicado: (2018)

Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer
por: Li, Xiaoqin, et al.
Publicado: (2022)

MiR-148a inhibits angiogenesis by targeting ERBB3()
por: Yu, Jing, et al.
Publicado: (2011)

miR‐148a suppresses inflammation in lipopolysaccharide‐induced endometritis
por: Jiang, Kangfeng, et al.
Publicado: (2019)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

The Connection between High Myopia Patients and MiR-708a or MiR-148 Expression Levels in Aqueous Studies of Visual Acuity
por: Shen, Jiang, et al.
Publicado: (2022)

MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome
por: Wang, Yuluan, et al.
Publicado: (2020)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
por: Bolayırlı, Ibrahim Murat, et al.
Publicado: (2022)

miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway
por: Alqurashi, Naif, et al.
Publicado: (2019)

The Effects of BMP-2, miR-31, miR-106a, and miR-148a on Osteogenic Differentiation of MSCs Derived from Amnion in Comparison with MSCs Derived from the Bone Marrow
por: Manochantr, Sirikul, et al.
Publicado: (2017)

Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer
por: Han, Mi-Soon, et al.
Publicado: (2018)

miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
por: Henriques, Daniel G., et al.
Publicado: (2023)

Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression
por: Tang, Guojun, et al.
Publicado: (2022)

Role of miR-148a in Hepatitis B Associated Hepatocellular Carcinoma
por: Yuan, Ke, et al.
Publicado: (2012)

Identification of miR-148a as a novel regulator of cholesterol metabolism
por: Goedeke, Leigh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2smau2hpdatqb6dn71ukipbi7n